Adjust Expectations Before Multi-Flap Reconstruction for Head and Neck Cancer Adjust Expectations Before Multi-Flap Reconstruction for Head and Neck Cancer
Surgeons should weigh the curative potential, as well as functional and aesthetic outcomes and costs, before undertaking complex, multi-flap reconstructions in head and neck cancer patients, researchers say.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - July 13, 2018 Category: Surgery Tags: Plastic Surgery & Aesthetic Medicine News Source Type: news
Child cancer drug approved for NHS use
60% of children with high-risk neuroblastoma can be treated with dinutuximab beta Related items fromOnMedica One in 10 children in phase I cancer trials respond to drugs Children need access to cancer drug ‘goldmine’ NICE rejects adjuvant use of breast cancer drug New breast cancer drug ‘unaffordable’ for NHS Drug could double head and neck cancer survival (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 12, 2018 Category: UK Health Source Type: news
Research Reveals Immunotherapy More Effective in Men
For mesothelioma patients, immunotherapy is mostly available through clinical trials at this time. Immunotherapy is a relatively new way to treat cancer, and doctors still are learning who will respond best to these novel therapies. Newly released medical research has found men seem to respond better to immunotherapy than women. But this doesn’t mean immunotherapy is off the table for women with mesothelioma. You should learn all you can about how immunotherapy works, why it may or may not be right for you and how you can best prepare yourself if you decide an immunotherapy clinical trial is right for you. Thorough ...
Source: Asbestos and Mesothelioma News - July 3, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news
Computer algorithm maps cancer resistance to drugs, therapy
(Johns Hopkins Medicine) New methods of studying the evolution of treatment resistance in head and neck cancer are being developed by researchers at the Johns Hopkins Kimmel Cancer Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 2, 2018 Category: International Medicine & Public Health Source Type: news
Anti-mucositis gel developed at UGR to be widely available by 2022
(University of Granada) Researchers from the University of Granada have developed new medication which could help to treat and prevent chemotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients. The melatonin compound, in the form of a gel, has now passed phases 1 and 2 of clinical trials and is expected to be on sale by 2022. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2018 Category: International Medicine & Public Health Source Type: news
New treatment may reverse drug resistance in mouth, neck cancers
A drug being tested for use against several cancers was found to be effective at reversing drug resistance in head and neck skin cancers, according to a study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 28, 2018 Category: Consumer Health News Source Type: news
CEL-SCI wins $2.9M in CRO legal battle
Score one for the little guy. After a four-year legal battle, immunotherapy maker CEL-SCI Corporation has won the first-ever breach-of-contract case against a contract research organization, or CRO. In a final and binding decision, an arbitrator concluded that CRO inVentiv knowingly and fraudulently misled CEL-SCI with regard to enrollment projections for a clinical trial of CEL-SCI’s immunotherapy treatment for head and neck cancer. The arbitrator also said inVentiv used “scorched earth” litigation tactics and awarded CEL-SCI $2.9 million in damages, according to a statement from Vienna, Va.-based C...
Source: Mass Device - June 27, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Legal News Oncology Research & Development cel-sci inVentiv Source Type: news
New diagnosis method could help spot head and neck cancers earlier
(IOP Publishing) Oral squamous cell carcinomas (OSCCs) are the most common head and neck cancers, but are often diagnosed late.Now, researchers in Germany have developed a new cell-based test that could help provide earlier and more reliable diagnosis of OSCCs.Writing in Convergent Science Physical Oncology, the researchers explain how they tested the mechanical properties of OSCC cells, and found they were 'softer' than benign cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news
7 medtech stories we missed this week: June 22, 2018
[Image from unsplash.com]From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in India for its Radixact X9 System. The approval allows the company to sell the TomoTherapy platform while allowing hospitals throughout India to import the system. The Radixact and TomoTherapy Systems are radiation th...
Source: Mass Device - June 22, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Diagnostics Endoscopic / Arthroscopic Food & Drug Administration (FDA) Hospital Care Imaging Patient Monitoring Regulatory/Compliance Ultrasound Accuray Inc. Arcuro Medical BTG Masimo MedTech NuSight P Source Type: news
Success of dental implants after head and neck radiation therapy?
What are the factors potentially influencing the success of dental implants placed in patients with head and neck cancer who underwent radiation therapy?The postSuccess of dental implants after head and neck radiation therapy? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - June 21, 2018 Category: Dentistry Authors: osseonews Tags: Research and News Surgical Source Type: news
A Better Regimen for Head and Neck Cancer?
(MedPage Today) -- Study backs combo of chemotherapy, cetuximab, and radiotherapy (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 13, 2018 Category: Hematology Source Type: news
Factors associated with increased risk of suicide among survivors of head and neck cancer: a population-based analysis - Osazuwa-Peters N, Arnold LD, Loux TM, Varvares MA, Schootman M.
OBJECTIVES: Cancer diagnosis is considered an independent predictor of suicide. We aimed to determine whether gender and human papillomavirus (HPV)-relatedness are associated with increased risks of suicide in the head and neck cancer (HNC) population. ... (Source: SafetyLit)
Source: SafetyLit - June 12, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news
Prevalence and risk factors of suicidal ideation among patients with head and neck cancer: longitudinal study - Henry M, Rosberger Z, Bertrand L, Klassen C, Hier M, Zeitouni A, Kost K, Mlynarek A, Richardson K, Black M, MacDonald C, Zhang X, Chartier G, Frenkiel S.
OBJECTIVEs (1) Determine 1-year period prevalence of suicidal ideation, suicide attempt, and completed suicide among patients newly diagnosed with a first occurrence of head and neck cancer (HNC). (2) Characterize stability and trajectory of suicidal ideat... (Source: SafetyLit)
Source: SafetyLit - June 11, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news
ASCO: Undertreatment Seen for Women With Head & amp; Neck Cancer
THURSDAY, June 7, 2018 -- Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, according to a study presented at the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2018 Category: Pharmaceuticals Source Type: news
Melatonin Gel May Reduce Oral Mucositis From Chemo, Radiation Melatonin Gel May Reduce Oral Mucositis From Chemo, Radiation
Data from a phase II trial of Mucomel (3% melatonin gel) suggest the formulation may reduce the risk of oral mucositis resulting from chemo and radiotherapy for head and neck cancers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 6, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Colorado study suggests new combination treatment against relapsed head and neck cancer
(University of Colorado Anschutz Medical Campus) 'EphB4-ephrin-B2 inhibitors are currently in clinical trials in other disease settings, and our work shows that it might be successful in combination with EGFR inhibition in advanced head and neck cancers as well,' says Sana Karam, M.D., Ph.D. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 6, 2018 Category: International Medicine & Public Health Source Type: news
‘Surviving’ cancer is a journey of readjustment
Having been treated for head and neck cancer, Genevieve Fox looked for the yellow brick road back to her old, pre-cancer self, but the truth is it really isn ’t like that“Hey cancer, you picked the wrong bitch.”“Been there. Beat that.”Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 3, 2018 Category: Science Authors: Genevieve Fox Tags: Life and style Psychology Science Health & wellbeing Cancer Society Source Type: news
Trial Breast Cancer Drug Shows 'Modest' Benefit
As the researchers explained, taselisib has already proven beneficial for people fighting head-and-neck cancers or certain gynecological tumors. Would it do the same for hormone-sensitive breast cancers? (Source: WebMD Health)
Source: WebMD Health - June 2, 2018 Category: Consumer Health News Source Type: news
Gender Disparities in Head and Neck Cancer Treatment?
John SchieszerJun 1, 2018A California study showed women are significantly undertreated for head and neck cancer, with several factors possibly accounting for the disparity. (Source: CancerNetwork)
Source: CancerNetwork - June 1, 2018 Category: Cancer & Oncology Authors: A Source Type: news
‘ Holy Grail ’ Blood Test May Detect Cancer Before Tumors Form
CLEVELAND, OH (CBS Local) – A new type of blood screening is being called the “holy grail of cancer research” by scientists who say the test can detect the disease before tumors even form in the body. The Details: A new blood test is successfully finding cancer before tumors form A liquid biopsy tests human DNA for genetic mutations linked to cancer The tests proved capable of detecting several hard-to-treat forms of the disease “This is potentially the holy grail of cancer research, to find cancers that are currently hard to cure at an earlier stage when they are easier to cure,” lead ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 1, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Blood Test Cancer Local TV talkers Source Type: news
Could Mesothelioma Chemotherapy Ever Be Obsolete?
Oncologist Dr. Arek Dudek at Regions Hospital Cancer Care Center in St. Paul, Minnesota, believes his clinical trial involving a novel immunotherapy combination could change the way doctors treat pleural mesothelioma. Dudek is opening the only Phase II trial evaluating the combination of nivalumab (Opdivo) and ramucirumab (Cyramza) for previously treated mesothelioma patients. “This strategy – if successful, like we think it will be – could make treatment with chemotherapy obsolete,” Dudek told Asbestos.com. “People can be really excited about this one.” He based his optimism on the pote...
Source: Asbestos and Mesothelioma News - June 1, 2018 Category: Environmental Health Authors: Walter Pacheco Source Type: news
Smart Technology May Improve Head and Neck Cancer Care
In a CYCORE trial, mobile technology improved patient tracking, enabling clinicians to detect concerning symptoms early and respond quicker. (Source: CancerNetwork)
Source: CancerNetwork - May 25, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Conferences/ASCO Head & Neck Cancer News Source Type: news
Compound in citrus oil could reduce dry mouth in head, neck cancer patients
(Stanford Medicine) A compound found in citrus oils could help alleviate dry mouth caused by radiation therapy in head and neck cancer patients, according to a new study by researchers at the Stanford University School of Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 21, 2018 Category: Cancer & Oncology Source Type: news
Remote Tracking Reduces Symptoms in Head and Neck Cancer Remote Tracking Reduces Symptoms in Head and Neck Cancer
Remote monitoring of symptoms using mobile technology appeared to reduce the severity of symptoms in patients with head and neck cancer treated with radiation.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Head and neck cancer patients report lessened symptoms when monitored remotely
Head and neck cancer patients who were given smartphone and sensor technology as a way to remotely monitor their symptoms reported less severe symptoms from their cancer and treatment than their counterparts who did receive the technology, according to a recent study presented at the American Society of Clinical Oncology annual meeting. (Source: mobihealthnews)
Source: mobihealthnews - May 17, 2018 Category: Information Technology Source Type: news
THE IADR/AADR publish JDR special issue on head and neck cancer
(International& American Associations for Dental Research) The International and American Associations for Dental Research (IADR/AADR) have published a special issue in the Journal of Dental Research (JDR) on head and neck cancer. Dr. Jacques E. N ö r, University of Michigan, Ann Arbor, USA, and Dr. J. Silvio Gutkind, University of California, San Diego, USA, served as the guest editors of this special issue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2018 Category: Cancer & Oncology Source Type: news
Use of mobile and sensor technology lowers symptom severity for people with head and neck cancer
(American Society of Clinical Oncology) A federally funded, randomized clinical trial of 357 people receiving radiation for head and neck cancer, using mobile and sensor technology to remotely monitor patient symptoms, resulted in less severe symptoms related to both the cancer and its treatment (both general and cancer-related). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2018 Category: International Medicine & Public Health Source Type: news
Scientific expert reaction to new Cochrane Review on HPV vaccine for cervical cancer prevention in girls and women
This study looks at a collection of studies looking at the benefit of HPV vaccines in reducing pre cervical cancer lesions. HPV also causes many other serious cancers (especially head and neck). In time, as more people have been vaccinated, we will see a reduction in all HPV cancers. The HP V vaccine is one of a number of vaccines using virus like particles (VLPS) which have been shown to be very safe over the last 35 years. “The Cochrane library of reviews has a very rigorous assessment process of all their reviews. “The review only looked at cervical precancer (in women and girls),...
Source: Cochrane News and Events - May 8, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Celecoxib May Help Curb Opioid Use After Head and Neck Cancer Surgery Celecoxib May Help Curb Opioid Use After Head and Neck Cancer Surgery
Celecoxib is associated with lower perioperative opioid requirements after head and neck surgery with free tissue reconstruction, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 30, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news
4 Trends Advancing Medtech
For the past 20 years, the Medical Design Excellence Awards have celebrated medical products that improve the quality and accessibility of healthcare. Our finalists this year carry on this tradition, while also keeping in step with today’s high-tech digital and consumer trends. With the help of our esteemed jurors, we have identified four key trends in this year’s group of finalists: risk reduction; faster, more-efficient healthcare delivery; the influence of the Internet of Things; and the consumerization of healthcare. We’ve been tracking a few of these trends in past awards programs, so they’re n...
Source: MDDI - April 27, 2018 Category: Medical Devices Authors: Daphne Allen Tags: MD & M East (New York) Design Source Type: news
Heavy Drinking Could Increase ‘ Bad ’ Bacteria In Mouth, Study Finds
CBS Local – People who drink more than the recommended daily limit of alcohol may harbor an unhealthy mix of bacteria in their mouths, a new study suggests. Researchers found that compared with nondrinkers, those who drank heavily had fewer “good” bacteria in their mouths. They were also hosting more “bad” bacteria — including bugs that have been linked to gum disease, heart disease, and cancer. The study is one of the latest to look at what factors influence the human “microbiome” – the trillions of bacteria and other microbes that naturally dwell in the...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 25, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Drinking Gum Disease Local TV Microbiome talkers Source Type: news
Novel TKI Plus Chemo Dramatically Shrank Advanced Head & amp; Neck Tumors
AZD1775, a small-molecule, WEE1-targeting TKI, significantly shrunk tumors when administered in combination with cisplatin and docetaxel in a phase I trial. (Source: CancerNetwork)
Source: CancerNetwork - April 25, 2018 Category: Cancer & Oncology Authors: Anne Landry Tags: Head & Neck Cancer Head and Neck Cancer Targets News Source Type: news
A defect in KCa3.1 channel activity limits the ability of CD8+ T cells from cancer patients to infiltrate an adenosine-rich microenvironment
The limited ability of cytotoxic T cells to infiltrate solid tumors hampers immune surveillance and the efficacy of immunotherapies in cancer. Adenosine accumulates in solid tumors and inhibits tumor-specific T cells. Adenosine inhibits T cell motility through the A2A receptor (A2AR) and suppression of KCa3.1 channels. We conducted three-dimensional chemotaxis experiments to elucidate the effect of adenosine on the migration of peripheral blood CD8+ T cells from head and neck squamous cell carcinoma (HNSCC) patients. The chemotaxis of HNSCC CD8+ T cells was reduced in the presence of adenosine, and the effect was greater o...
Source: Signal Transduction Knowledge Environment - April 24, 2018 Category: Science Authors: Chimote, A. A., Balajthy, A., Arnold, M. J., Newton, H. S., Hajdu, P., Qualtieri, J., Wise-Draper, T., Conforti, L. Tags: STKE Research Articles Source Type: news
Celecoxib Lowers Opioid Use Post Head & amp; Neck Cancer Surgery
Decreased opioid use seen after head and neck cancer surgery with free tissue reconstruction (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 23, 2018 Category: Cancer & Oncology Tags: Oncology, ENT, Pharmacy, Surgery, Anesthesiology & amp; Pain, Journal, Source Type: news
Celecoxib Lowers Opioid Use Post Head & amp; Neck Cancer Surgery
MONDAY, April 23, 2018 -- For patients undergoing head and neck cancer (HNC) surgery, perioperative use of celecoxib is associated with reduced use of opioids after surgery, according to a study published online April 18 in JAMA Otolaryngology-Head... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 23, 2018 Category: Pharmaceuticals Source Type: news
Most Smokers With Head and Neck Cancer Have Tried to Quit
THURSDAY, April 19, 2018 -- Most active smokers with head and neck squamous cell carcinoma (HNSCC) have made one or more quit attempts, according to a study published online April 12 in JAMA Otolaryngology-Head& Neck Surgery. Samir S.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2018 Category: Pharmaceuticals Source Type: news
Abramson Cancer Canter studies show promise of immunotherapy combinations, including CAR T
(University of Pennsylvania School of Medicine) As immunotherapies continue to make up a larger share of new cancer drugs, researchers are looking for the most effective ways to use these cutting edge treatments in combination with each or with other pre-existing options. New studies from the Abramson Cancer Center are providing clues on potentially effective combinations with CAR T therapy in brain cancer as well as a novel therapeutic target in head and neck cancer, and also providing greater understanding of the mechanisms of resistance in pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2018 Category: Cancer & Oncology Source Type: news
Study explores carbohydrates' impact on head, neck cancers
(University of Illinois at Urbana-Champaign) Consuming high amounts of carbohydrates and various forms of sugar during the year prior to treatment for head and neck cancer may increase patients' risks of cancer recurrence and mortality, a new study reports.However, eating moderate amounts of fats and starchy foods such as whole grains, potatoes and legumes after treatment could have protective benefits, reducing patients' risks of disease recurrence and death, said lead author Anna E. Arthur, a professor of food science and human nutrition at the University of Illinois. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 12, 2018 Category: International Medicine & Public Health Source Type: news
5 Trends Medtech Should Be Talking About
Recently I chatted with Candace Roulo, managing editor of Advanced Manufacturing Now, about some of the most important trends in medtech and the technologies that are taking the industry to the next level. Click below to listen to the podcast, or read on for select highlights of the conversation – what I consider to be five trends medtech professionals should be talking about. 128-Advanced_Manufacturing_Now-UBM.mp3 Explore all of these trends in depth at the BIOMEDevice Boston Conference and Expo, April 18-19, 2018. Use promo code "SAVE100" for $100 off conference registration and f...
Source: MDDI - April 6, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: BIOMEDevice Boston Business Digital Health Source Type: news
NIH researchers use genomics to set squamous cell carcinomas apart from other cancers
Results could advance treatments for head and neck and other cancers. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - April 5, 2018 Category: American Health Source Type: news
Mesothelioma Clinical Trial Opens with Optimism in South Florida
Dr. Chukwuemeka Ikpeazu at the Sylvester Comprehensive Cancer Center has brought hope — where once there was none — to patients in South Florida with unresectable pleural mesothelioma. Ikpeazu is the principal investigator in the multicenter phase II clinical trial involving the much-anticipated immunotherapy drug durvalumab. Pharmaceutical giant AstraZeneca manufactures the drug under the brand name Imfinzi. “I am optimistic, very, very optimistic that this drug will be effective for these patients,” Ikpeazu told Asbestos.com. “All the data, all the earlier studies, are encouraging.” He...
Source: Asbestos and Mesothelioma News - April 4, 2018 Category: Environmental Health Authors: Daniel King Source Type: news
Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors
This review concludes that keratinocyte growth factor is beneficial in the prevention of oral mucositis in adults who are receiving radiotherapy to the head and neck with cisplatin or fluorouracil, or chemotherapy alone for mixed solid and haematological cancers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 28, 2018 Category: Consumer Health News Source Type: news
Immunotherapy Drugs Causing Vision Issues
The U.S. Food and Drug Administration (FDA) is investigating the potential for three immunotherapy drugs to cause retinal detachment and vision loss. The FDA will consider adding eye toxicities to the warning labels for pembrolizumab (Keytruda), nivolumab (Opdivo) and ipilimumab (Yervoy), which have shown promise in clinical trials involving malignant mesothelioma. All three have already been approved by the FDA for use with metastatic melanoma. Keytruda and Opdivo also have approval for head and neck cancers, colorectal cancers and certain non-small cell lung cancers. The FDA used its Adverse Event Reporting System (FAERS...
Source: Asbestos and Mesothelioma News - March 27, 2018 Category: Environmental Health Authors: Daniel King Source Type: news
Accurately identifying aggressive head and neck cancers
(Case Western Reserve University) Case Western Reserve University's Center for Computational Imaging and Personalized Diagnostics (CCIPD) is leading a partnership working toward the first clinical trials to determine the aggressiveness of-and appropriate treatment for-certain head and neck cancers.Head and neck cancers (squamous cell carcinomas or HNSCC) represent more than half-a-million cases and 300,000 deaths a year, making them the sixth-leading cancer worldwide, according to the World Health Organization. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 27, 2018 Category: Cancer & Oncology Source Type: news
No Chemo Benefit for Head and Neck Skin Cancer
(MedPage Today) -- Radiotherapy alone provides similar disease control (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 20, 2018 Category: Primary Care Source Type: news
Hidden Cancers Uncovered With Glowing Dyes
PHILADELPHIA (AP) — It was an ordinary surgery to remove a tumor — until doctors turned off the lights and the patient’s chest started to glow. A spot over his heart shined purplish pink. Another shimmered in a lung. They were hidden cancers revealed by fluorescent dye, an advance that soon may transform how hundreds of thousands of operations are done each year. Surgery has long been the best way to cure cancer. If the disease recurs, it’s usually because stray tumor cells were left behind or others lurked undetected. Yet there’s no good way for surgeons to tell what is cancer and what is not...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 15, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Cancer Dr. Mallika Marshall Local TV TumorGlow Source Type: news
TAE Life Sciences raises $40m for neutron beam cancer treatment
TAE Life Sciences said yesterday it raised $40 million in venture capital to support the development of its neutron beam technology designed as a potential treatment for head and neck, glioblastoma multiforme and other cancers. The newly launched Foothill Ranch, Calif.-based company, which operates as a subsidiary of fusion energy company TAE Technologies, is developing neutron beam technology intended for Boron Neutron Capture Therapy. As part of the company’s launch, it announced that it is partnering with Chinese BNCT company Neuboron Medtech, and that its first neutron beam system will be delivered to Neuboron fo...
Source: Mass Device - March 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology taelifesciences Source Type: news
HPV Causes Cancer — A Vaccine Can Prevent It
More than 30,000 Americans develop one of several kinds of cancer each year caused by the human papillomavirus (HPV) — some of which will kill them. Fortunately, physicians say a too-seldom-used vaccine can protect people from HPV-caused cancers of the cervix, vulva, vagina, penis, anus, and oropharynx (head and neck). (Source: TMA News Room)
Source: TMA News Room - March 1, 2018 Category: Consumer Health News Source Type: news
Multimodal Imaging of Head and Neck Squamous Cell Carcinoma Multimodal Imaging of Head and Neck Squamous Cell Carcinoma
Review standard and multimodal cross-sectional imaging for evaluation and management of head and neck SCC.Cancer Control: Journal of the Moffitt Cancer Center (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 27, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news